Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-17-003706
Filing Date
2017-05-01
Accepted
2017-05-01 17:35:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 20754
2 GRAPHIC g201422g06d65.jpg GRAPHIC 2503
3 GRAPHIC g201422g82t59.jpg GRAPHIC 3414
  Complete submission text file 0000950123-17-003706.txt   30283
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

EIN.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations